203 related articles for article (PubMed ID: 33003204)
21. An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma.
Chen Y; Li ZY; Zhou GQ; Sun Y
Clin Cancer Res; 2021 Jan; 27(1):330-341. PubMed ID: 33097495
[TBL] [Abstract][Full Text] [Related]
22. Prognosis Analysis and Validation of m
Lin S; Xu H; Zhang A; Ni Y; Xu Y; Meng T; Wang M; Lou M
Front Oncol; 2020; 10():541401. PubMed ID: 33123464
[TBL] [Abstract][Full Text] [Related]
23. M6A Regulatory Genes Play an Important Role in the Prognosis, Progression and Immune Microenvironment of Pancreatic Adenocarcinoma.
Xu F; Zhang Z; Yuan M; Zhao Y; Zhou Y; Pei H; Bai L
Cancer Invest; 2021 Jan; 39(1):39-54. PubMed ID: 33176521
[TBL] [Abstract][Full Text] [Related]
24. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway.
Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L
RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587
[TBL] [Abstract][Full Text] [Related]
25. N
Sun Y; Li S; Yu W; Zhao Z; Gao J; Chen C; Wei M; Liu T; Li L; Liu L
Cell Death Dis; 2020 Oct; 11(10):836. PubMed ID: 33037176
[TBL] [Abstract][Full Text] [Related]
26. Gene Signatures and Prognostic Values of m6A Regulators in Hepatocellular Carcinoma.
Wang P; Wang X; Zheng L; Zhuang C
Front Genet; 2020; 11():540186. PubMed ID: 33133142
[TBL] [Abstract][Full Text] [Related]
27. N
Huo FC; Zhu ZM; Pei DS
Cell Prolif; 2020 Nov; 53(11):e12921. PubMed ID: 33029866
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of a m
Kong W; Li X; Xu H; Gao Y
Biomark Med; 2020 Sep; 14(13):1217-1228. PubMed ID: 33021385
[No Abstract] [Full Text] [Related]
29. Comprehensive Analysis of the Expression, Relationship to Immune Infiltration and Prognosis of TIM-1 in Cancer.
Kong X; Fu M; Niu X; Jiang H
Front Oncol; 2020; 10():1086. PubMed ID: 33014768
[TBL] [Abstract][Full Text] [Related]
30. Integrated analysis of tumor mutation burden and immune infiltrates in endometrial cancer.
Zhou H; Chen L; Lei Y; Li T; Li H; Cheng X
Curr Probl Cancer; 2021 Apr; 45(2):100660. PubMed ID: 33012523
[TBL] [Abstract][Full Text] [Related]
31. RMDisease: a database of genetic variants that affect RNA modifications, with implications for epitranscriptome pathogenesis.
Chen K; Song B; Tang Y; Wei Z; Xu Q; Su J; de Magalhães JP; Rigden DJ; Meng J
Nucleic Acids Res; 2021 Jan; 49(D1):D1396-D1404. PubMed ID: 33010174
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value and immune cell infiltration of hypoxic phenotype-related gene signatures in glioblastoma microenvironment.
Xiao K; Tan J; Yuan J; Peng G; Long W; Su J; Xiao Y; Xiao Q; Wu C; Qin C; Hu L; Liu K; Liu S; Zhou H; Ning Y; Ding X; Liu Q
J Cell Mol Med; 2020 Nov; 24(22):13235-13247. PubMed ID: 33009892
[TBL] [Abstract][Full Text] [Related]
33. Structural and Dynamic Insights into Redundant Function of YTHDF Proteins.
Li Y; Bedi RK; Moroz-Omori EV; Caflisch A
J Chem Inf Model; 2020 Dec; 60(12):5932-5935. PubMed ID: 33073985
[TBL] [Abstract][Full Text] [Related]
34. Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma.
Sun Z; Jing C; Xiao C; Li T; Wang Y
Aging (Albany NY); 2020 Nov; 12(21):22078-22094. PubMed ID: 33177247
[TBL] [Abstract][Full Text] [Related]
35. The Prognostic and Therapeutic Value of the Mutational Profile of Blood and Tumor Tissue in Head and Neck Squamous Cell Carcinoma.
Wilson HL; D'Agostino RB; Meegalla N; Petro R; Commander S; Topaloglu U; Zhang W; Porosnicu M
Oncologist; 2021 Feb; 26(2):e279-e289. PubMed ID: 33098199
[TBL] [Abstract][Full Text] [Related]
36. Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide.
Oweida AJ; Mueller AC; Piper M; Milner D; Van Court B; Bhatia S; Phan A; Bickett T; Jordan K; Proia T; Schulick R; Messersmith WA; Del Chiaro M; Clambey E; Gough MJ; Williams J; Hansen K; Goodman K; Karam SD
Cancer Immunol Immunother; 2021 Apr; 70(4):989-1000. PubMed ID: 33097963
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanisms of breast cancer chemoresistance by immune checkpoints.
Dastmalchi N; Safaralizadeh R; Baghbanzadeh A; Hajiasgharzadeh K; Roshani Asl E; Amini M; Baradaran B
Life Sci; 2020 Dec; 263():118604. PubMed ID: 33096117
[TBL] [Abstract][Full Text] [Related]
38. Galectin-9-based immune risk score model helps to predict relapse in stage I-III small cell lung cancer.
Chen P; Zhang L; Zhang W; Sun C; Wu C; He Y; Zhou C
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33082168
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype.
Qin N; Ma Z; Wang C; Zhang E; Li Y; Huang M; Chen C; Zhang C; Fan J; Gu Y; Xu X; Yang L; Wei X; Yin R; Jiang Y; Dai J; Jin G; Xu L; Hu Z; Shen H; Ma H
Theranostics; 2020; 10(24):11264-11277. PubMed ID: 33042282
[No Abstract] [Full Text] [Related]
40. TILRR (FREM1 isoform 2) is a prognostic biomarker correlated with immune infiltration in breast cancer.
Xu XY; Guo WJ; Pan SH; Zhang Y; Gao FL; Wang JT; Zhang S; Li HY; Wang R; Zhang X
Aging (Albany NY); 2020 Oct; 12(19):19335-19351. PubMed ID: 33031059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
